Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors
about
Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migrationSafety of targeting tumor endothelial cell antigensCancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?Biomarkers Discovery for Colorectal Cancer: A Review on Tumor Endothelial Markers as Perspective CandidatesCharacterization of TEM1/endosialin in human and murine brain tumors.Endosialin expression in relation to clinicopathological and biological variables in rectal cancers with a Swedish clinical trial of preoperative radiotherapy.Development of 124I immuno-PET targeting tumor vascular TEM1/endosialin.CD248 facilitates tumor growth via its cytoplasmic domain.Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins.Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancerEndosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications.Characteristics of human Ewing/PNET sarcoma models.TGFβ-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cellsA first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumorsTumor stroma-associated antigens for anti-cancer immunotherapy.Conditionally replicative adenoviral vectors for malignant glioma.Secretome of Olfactory Mucosa Mesenchymal Stem Cell, a Multiple Potential Stem CellCharacterisation of fibroblast-like synoviocytes from a murine model of joint inflammation.CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanismTumor endothelial marker 1-specific DNA vaccination targets tumor vasculature.Novel antibody probes for the characterization of endosialin/TEM-1.Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies.Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma.Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model.The stromal cell antigen CD248 (endosialin) is expressed on naive CD8+ human T cells and regulates proliferation.Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2.Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells.Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213).CD248 and its cytoplasmic domain: a therapeutic target for arthritis.
P2860
Q24673788-8DDFFF8D-F36D-4D2E-9E0A-ACD1C0BD0D03Q26748863-778E92EB-0AE2-4180-8189-4B4143487624Q26778150-CA94C42F-1591-47D4-99D3-FEEAF2256063Q28071510-1B48C9C4-52DB-4526-B459-5B23BD0B767AQ30932017-E69F4465-47D3-4CF1-8589-CA34D84F610AQ33833143-8B9D39C3-2390-4990-9F88-64D46346BACAQ33872675-D61165CE-D863-4255-9FF8-E6A65C4220E7Q33891662-5E6BBD1E-8D71-4F1F-A886-2FEEFCE09AACQ34100831-BFDC343D-2E8C-47C2-B1CA-A3E995474D68Q34334475-A50AEC9B-AE11-4CAB-A565-F4F99D02C5F4Q34481202-99D39D35-72B1-472C-9FB1-BC23BCD5DC79Q35008659-6CDFDB99-D4F9-4941-91B9-F5F3F4169513Q35098665-78A237D7-BF11-4ED2-BE65-149B614B4B30Q36182112-BB9DE82A-78F7-4495-8E37-2D39C21EBAC2Q36284238-3773CF82-E729-4EC5-847D-8D87ECDC1665Q36370081-84767196-B2E4-4AF7-8BBB-70CCC8D020B4Q36579180-2B801794-B2BF-46A2-B076-8BDFFB1EC677Q36903356-9A253065-59DE-4863-BD8A-F20BC54279DDQ37085580-A73DAE19-4496-4CC0-8554-FFEEDC99FB05Q37679962-345408E0-728E-471A-BBB9-2994603C5244Q37688385-8608B62F-4433-497E-AF61-7878A2C3E11DQ38330549-D0C163EA-22F2-4E22-8122-CC526A735FA7Q38428184-19F3FFBC-6C7C-4CFF-B334-8C4CE12F79A9Q38662532-16AA8CCB-90BD-4A03-82FD-5F6BE904110CQ39564241-31161A05-4D16-4DBF-8C40-701645C5FD0CQ39936613-4F7DF7D8-EBE9-4C12-B5F9-518C5078D336Q42269585-F9F5C471-9894-445F-9917-7736FEEDB510Q45391515-14E36628-671F-47E3-BEE5-3323227BE2B0Q46046772-F51CA863-65AF-4AC1-87DB-566E6642611CQ48324213-8705AA5F-611B-472D-8561-34C233318720Q49092320-9E2C97D7-C0D5-49DD-AF68-356B3AEEAE37
P2860
Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Human endosialin (tumor endoth ...... nant and invasive brain tumors
@ast
Human endosialin (tumor endoth ...... nant and invasive brain tumors
@en
Human endosialin (tumor endoth ...... nant and invasive brain tumors
@nl
type
label
Human endosialin (tumor endoth ...... nant and invasive brain tumors
@ast
Human endosialin (tumor endoth ...... nant and invasive brain tumors
@en
Human endosialin (tumor endoth ...... nant and invasive brain tumors
@nl
prefLabel
Human endosialin (tumor endoth ...... nant and invasive brain tumors
@ast
Human endosialin (tumor endoth ...... nant and invasive brain tumors
@en
Human endosialin (tumor endoth ...... nant and invasive brain tumors
@nl
P2093
P2860
P3181
P356
P1476
Human endosialin (tumor endoth ...... nant and invasive brain tumors
@en
P2093
James Neal
Jennifer Brady
Nagarajan Sadakar
P2860
P304
P3181
P356
10.1093/JNEN/63.12.1274
P407
P577
2004-12-01T00:00:00Z